Dmitry Nepomnayshy to Diabetes Mellitus, Type 2
This is a "connection" page, showing publications Dmitry Nepomnayshy has written about Diabetes Mellitus, Type 2.
Connection Strength
0.688
-
Doyon L, Das S, Sullivan T, Rieger-Christ K, Sherman J, Roque S, Nepomnayshy D. Can genetics help predict efficacy of bariatric surgery? An analysis of?microRNA profiles. Surg Obes Relat Dis. 2020 Nov; 16(11):1802-1807.
Score: 0.428
-
Gersin KS, Rothstein RI, Rosenthal RJ, Stefanidis D, Deal SE, Kuwada TS, Laycock W, Adrales G, Vassiliou M, Szomstein S, Heller S, Joyce AM, Heiss F, Nepomnayshy D. Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates. Gastrointest Endosc. 2010 May; 71(6):976-82.
Score: 0.210
-
Levine A, Ramos A, Escalona A, Rodriguez L, Greve JW, Janssen I, Rothstein R, Nepomnayshy D, Gersin KS, Melanson D, Lamport R, Fishman E, Malomo K, Kaplan LM, Neto MG. Radiographic appearance of endoscopic duodenal-jejunal bypass liner for treatment of obesity and type 2 diabetes. Surg Obes Relat Dis. 2009 May-Jun; 5(3):371-4.
Score: 0.049